Syk kinase inhibitors as treatment for malaria
AssigneePurdue Research Foundation
InventorsPHILIP S. LOW, FRANCESCO MICHELANGELO TURRINI, KRISTINA ROSE KESELY, ANTONELLA PANTALEO
Life of this patent
Estimating the term…
Abstract
The disclosure relates to methods, compositions, and kits for treatment of parasite-mediated disease. In one embodiment, the disclosure relates to compounds, compositions, methods and kits for the treatment of malaria. In still another embodiment, the disclosure relates to a method for treating malaria comprising the use of a Syk kinase inhibitor.
Claims16
1-20. (canceled)
A method comprising administering at least one compound that inhibits band 3 phosphorylation in red blood cells to a subject in need thereof, wherein the at least one compound is not imatinib.
Dependencies are inferred from the claim text.